|
answer text |
<p>The Department’s National Institute for Health Research (NIHR) funds a wide range
of research relating to Parkinson’s disease through its programmes, fellowship schemes,
research centres and units, clinical research facilities and the NIHR Clinical Research
Network.</p><p> </p><p> </p><p> </p><p>Major investments that relate fully or partially
to Parkinson’s disease include:</p><p> </p><p> </p><p> </p><p>- £3.5 million for the
research theme on dementia and neurodegenerative disease at the NIHR Cambridge Biomedical
Research Centre (2012-17);</p><p> </p><p>- £3.1 million for the research theme on
neuroscience at the NIHR Imperial Biomedical Research Centre (2012-17);</p><p> </p><p>-
£3.0 million for the research theme on functional neuroscience and imaging at the
NIHR Oxford Biomedical Research Centre (2012-17);</p><p> </p><p>- £2.0 million for
a programme of research to inform clinical management of visual hallucinations associated
with Parkinson’s disease and other conditions (2012-18);</p><p> </p><p>- £1.9 million
for a trial of the effectiveness of an intervention to prevent falls among people
with Parkinson’s disease (2013-17); and</p><p> </p><p>- £1.3 million for an evaluation
of short-term integrated palliative care services to optimise care for people with
advanced long-term neurological conditions (2014-18).</p><p> </p>
|
|